Slide 1Analysis of the Epidermal Growth Factor Receptor and K-Ras genes in patients with Non-small Cell Lung Cancer H. Mugalaasi 1, J. Davies 2, L Medley 2, D Talbot 2, R.…

1. THERE ARE SO MANYPROMISING AGENTS COMING TO TREAT COLORECTAL CANCERJohanna Bendell, MDDirector, GI Oncology Trials Sarah Cannon Research InstituteNashville, TN 2. What…

Slide 1 CALGB 80403 / ECOG 1206: Randomized Phase II Study of Standard Chemotherapy + Cetuximab for Metastatic Esophageal Cancer PC Enzinger, BA Burtness, DR Hollis, D Niedzwiecki,…

An Overview of Bridging Evaluations in Taiwan Chin-Fu Hsiao1, Mey Wang2, Herng-Der Chen2, Yu-Yi Hsu1 and Jen-pei Liu3 1 Division of Biostatistics and Bioinformatics National…

CALGB 80403 / ECOG 1206: Randomized Phase II Study of Standard Chemotherapy + Cetuximab for Metastatic Esophageal Cancer PC Enzinger, BA Burtness, DR Hollis, D Niedzwiecki,…

Slide 1 Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) in Non-Small Cell Lung Cancer (NSCLC) Victor Cohen, MDCM,…

Analysis of the Epidermal Growth Factor Receptor and K-Ras genes in patients with Non-small Cell Lung Cancer H. Mugalaasi1, J. Davies2, L Medley2, D Talbot2, R. Brito1, R.…

A genome-wide association study of polycystic ovary syndrome identified from electronic health recordsA genome-wide association study of polycystic ovary syndrome identified